CADASIL

被引:52
作者
Herve, D. [1 ]
Chabriat, H. [1 ]
机构
[1] Hop Lariboisiere, Ctr Reference Malad Vasc Rares Cerveau & Oeil CER, Serv Neurol, F-75010 Paris, France
关键词
CADASIL; dementia; genetics; AUTOSOMAL-DOMINANT ARTERIOPATHY; CONDITION CAUSING STROKE; CEREBRAL WHITE-MATTER; SUBCORTICAL INFARCTS; NOTCH3; MUTATIONS; LEUKOENCEPHALOPATHY CADASIL; IMAGING ABNORMALITIES; COGNITIVE IMPAIRMENT; LACUNAR INFARCTS; REVERSIBLE COMA;
D O I
10.1177/0891988710383570
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a dominantly inherited small artery disease that leads to dementia and disability in mid-life. The clinical presentation of CADASIL is variable between and within affected families and is characterized by symptoms including migraine with aura, subcortical ischemic events, mood disturbances, apathy, and cognitive impairment. The mean age at onset of symptoms is 45 years, with variable duration of the disease ranging from 10 to 40 years. In 1996, linkage studies mapped and identified mutations in the NOTCH3 gene on chromosome 19 as causative in CADASIL. Head magnetic resonance imaging (MRI) is always abnormal in participants with NOTCH3 mutations after age 35. Magnetic resonance imaging shows on T2-weighted images or fluid attenuation inversion recovery (FLAIR) sequence, widespread areas of increased signal in the white matter associated with focal hyperintensities in basal ganglia, thalamus, and brainstem. The pathologic hallmark of CADASIL is the presence of electron-dense granules in the media of arterioles that can be identified by electron microscopic evaluation of skin biopsies.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 99 条
  • [31] Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL
    Dichgans, Martin
    Markus, Hugh S.
    Salloway, Stephen
    Verkkoniemi, Auli
    Moline, Margaret
    Wang, Qin
    Posner, Holly
    Chabriat, Hugues S.
    [J]. LANCET NEUROLOGY, 2008, 7 (04) : 310 - 318
  • [32] Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis
    Dong, YB
    Hassan, A
    Zhang, ZY
    Huber, D
    Dalageorgou, C
    Markus, HS
    [J]. STROKE, 2003, 34 (01) : 203 - 205
  • [33] The spectrum of Notch3 mutations in 28 Italian CADASIL families
    Dotti, MT
    Federico, A
    Mazzei, R
    Bianchi, S
    Scali, O
    Conforti, FL
    Sprovieri, T
    Guidetti, D
    Aguglia, U
    Consoli, D
    Pantoni, L
    Sarti, C
    Inzitari, D
    Quattrone, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (05) : 736 - 738
  • [34] Ducros A, 1996, AM J HUM GENET, V58, P171
  • [35] DUYCKERTS C, 2008, HDB CLIN NEUROLOGY, V89
  • [36] CADASIL: Skin biopsy allows diagnosis in early stages
    Ebke, M
    Dichgans, M
    Bergmann, M
    Voelter, HU
    Rieger, P
    Gasser, T
    Schwendemann, G
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (06): : 351 - 357
  • [37] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
    Endres, M
    Laufs, U
    Huang, ZH
    Nakamura, T
    Huang, P
    Moskowitz, MA
    Liao, JK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8880 - 8885
  • [38] The spectrum of mutations for CADASIL diagnosis
    Federico, A
    Bianchi, S
    Dotti, MT
    [J]. NEUROLOGICAL SCIENCES, 2005, 26 (02) : 117 - 124
  • [39] A case of late-onset CADASIL with interhemispheric disconnection features
    Felician, O
    Barbeau, E
    Gavaret, M
    Pellissier, JF
    Tournier-Lasserve, E
    Poncet, M
    Ceccaldi, M
    [J]. JOURNAL OF NEUROLOGY, 2003, 250 (10) : 1242 - 1244
  • [40] Feuerhake F, 2002, ACTA NEUROPATHOL, V103, P188